在癌症治疗中使用 ingenol mebutate:机制,临床应用和未来方向
Ndapewoshali F Shafombabi1, Michael Knott2, Petrina Kapewangolo3
1Department of Biochemistry, Microbiology & Biotechnology, School of Science, University of Namibia, Windhoek, Namibia.
Medical oncology (Northwood, London, England)
|February 8, 2025
概括
英格诺甲酸 (IM) 通过破坏癌细胞和刺激免疫力表现出抗癌作用. 然而,安全问题,包括潜在的皮肤癌风险,限制了它的使用,需要进一步研究更广泛的瘤学应用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 恩格诺甲布酸 (IM) 是来自Euphorbia物种的二烯 Ester,通过细胞毒性和免疫调节表现出抗癌性质.
- 由于安全问题,IM的临床使用受到限制,尤其是与增加皮肤癌风险的潜在联系.
研究的目的:
- 审查作为抗癌剂的 ingenol mebutate (IM) 的作用机制,疗效,安全性和限制.
- 确定在癌症治疗中进一步发展IM的领域.
主要方法:
- 2010-2023年使用谷歌学者对英语文章的综合文献综述.
- 关键词包括"英格诺甲酸盐"",PEP005"和"癌症治疗".
- 包括标准侧重于药理性质,治疗机制,临床研究和安全性.
主要成果:
- IM 显示了双重的抗癌机制:线粒体功能障碍导致和通过蛋白激酶C激活免疫中介细胞毒性.
- 临床前研究表明,它对胰腺癌,结直肠癌和上皮癌具有有效性.
- 临床研究表明,尽管局部皮肤反应强烈,但在治疗行为性角质炎和非黑色素瘤皮肤癌方面取得了成功.
结论:
- 英格诺尔甲酸 (IM) 是一个有前途的药物,具有快速和强大的抗癌作用.
- 优化IM的安全概况和探索先进的输送系统对于扩大其临床应用至关重要.
- 需要进一步的研究来证实长期的疗效和更广泛的瘤学应用的潜力.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
